Kit A. Keller

501 total citations
10 papers, 344 citations indexed

About

Kit A. Keller is a scholar working on Health, Toxicology and Mutagenesis, Pediatrics, Perinatology and Child Health and Cancer Research. According to data from OpenAlex, Kit A. Keller has authored 10 papers receiving a total of 344 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Health, Toxicology and Mutagenesis, 3 papers in Pediatrics, Perinatology and Child Health and 2 papers in Cancer Research. Recurrent topics in Kit A. Keller's work include Effects and risks of endocrine disrupting chemicals (4 papers), Carcinogens and Genotoxicity Assessment (2 papers) and Birth, Development, and Health (2 papers). Kit A. Keller is often cited by papers focused on Effects and risks of endocrine disrupting chemicals (4 papers), Carcinogens and Genotoxicity Assessment (2 papers) and Birth, Development, and Health (2 papers). Kit A. Keller collaborates with scholars based in United States and Canada. Kit A. Keller's co-authors include Kok Wah Hew, Narsingh D. Agnish, Christopher M. Snyder, James L. Schardein, Shruti Aggarwal, Adrian Vella, Carmen Valcarce, John B. Buse, Imogene Dunn and David Jacobson‐Kram and has published in prestigious journals such as Science Translational Medicine, Toxicology and Applied Pharmacology and Toxicological Sciences.

In The Last Decade

Kit A. Keller

10 papers receiving 328 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kit A. Keller United States 8 97 91 88 74 52 10 344
Toshio Harigaya Japan 15 130 1.3× 116 1.3× 66 0.8× 40 0.5× 26 0.5× 33 471
Marie W. Taubeneck United States 12 93 1.0× 203 2.2× 80 0.9× 30 0.4× 45 0.9× 14 521
Julian I. Delic United Kingdom 11 72 0.7× 62 0.7× 37 0.4× 52 0.7× 67 1.3× 27 387
Karen Kilcoyne United Kingdom 12 228 2.4× 173 1.9× 111 1.3× 48 0.6× 73 1.4× 15 618
Marta Hoffmann Poland 11 74 0.8× 151 1.7× 20 0.2× 53 0.7× 25 0.5× 13 370
Mickaël Canouil France 12 151 1.6× 47 0.5× 43 0.5× 23 0.3× 70 1.3× 21 389
Michael L. Netzloff United States 13 172 1.8× 22 0.2× 98 1.1× 35 0.5× 35 0.7× 26 410
Tohru Kanzaki Japan 8 72 0.7× 46 0.5× 49 0.6× 25 0.3× 55 1.1× 16 407
Ursula Jacob-Müller Germany 10 100 1.0× 123 1.4× 20 0.2× 87 1.2× 16 0.3× 11 353
Azam Moosavi Iran 8 152 1.6× 28 0.3× 30 0.3× 35 0.5× 27 0.5× 10 322

Countries citing papers authored by Kit A. Keller

Since Specialization
Citations

This map shows the geographic impact of Kit A. Keller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kit A. Keller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kit A. Keller more than expected).

Fields of papers citing papers by Kit A. Keller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kit A. Keller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kit A. Keller. The network helps show where Kit A. Keller may publish in the future.

Co-authorship network of co-authors of Kit A. Keller

This figure shows the co-authorship network connecting the top 25 collaborators of Kit A. Keller. A scholar is included among the top collaborators of Kit A. Keller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kit A. Keller. Kit A. Keller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Vella, Adrian, et al.. (2019). Targeting hepatic glucokinase to treat diabetes with TTP399, a hepatoselective glucokinase activator. Science Translational Medicine. 11(475). 49 indexed citations
2.
Keller, Kit A., et al.. (2015). From Committees of RUSA: Meeting the Need for Library-based Financial Literacy Education. Reference & User Services Quarterly. 54(3). 47–51. 7 indexed citations
3.
Hew, Kok Wah & Kit A. Keller. (2003). Postnatal anatomical and functional development of the heart: A species comparison. Birth Defects Research Part B Developmental and Reproductive Toxicology. 68(4). 309–320. 75 indexed citations
4.
Jacobson‐Kram, David & Kit A. Keller. (2001). Toxicology testing handbook : principles, applications, and data interpretation. Marcel Dekker eBooks. 7 indexed citations
5.
Agnish, Narsingh D. & Kit A. Keller. (1997). The Rationale for Culling of Rodent Litters. Toxicological Sciences. 38(1). 2–6. 59 indexed citations
6.
Schardein, James L., et al.. (1989). Potential Human Developmental Toxicants and The Role of Animal Testing in Their Identification and Characterization. PubMed. 19(3). 251–339. 47 indexed citations
7.
Keller, Kit A.. (1988). Mice exposed in utero to 20 ppm benzene exhibit altered numbers of recognizable hematopoietic cells up to seven weeks after exposure. Fundamental and Applied Toxicology. 10(2). 224–232. 33 indexed citations
8.
Keller, Kit A. & Carroll A. Snyder. (1988). Mice Exposed in Utero to 20 ppm Benzene Exhibit Altered Numbers of Recognizable Hematopoietic Cells Up to Seven Weeks after Exposure. Toxicological Sciences. 10(2). 224–232. 2 indexed citations
9.
Keller, Kit A. & Christopher M. Snyder. (1986). Mice exposed in utero to low concentrations of benzene exhibit enduring changes in their colony forming hematopoietic cells. Toxicology. 42(2-3). 171–181. 37 indexed citations
10.
Keller, Kit A. & Shruti Aggarwal. (1983). Embryotoxicity of cisplatin in rats and mice. Toxicology and Applied Pharmacology. 69(2). 245–256. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026